What is NDC 72205-147?

72205-147 is the product NDC for olmesartan medoxomil-hydrochlorothiazide, Olmesartan medoxomil 20 mg/1; Hydrochlorothiazide 12.5 mg/1 tablet, film coated, listed with the FDA by Novadoz Pharmaceuticals LLC. It has 3 package NDCs, shown above in 10- and 11-digit form.

Novadoz Pharmaceuticals LLC, NDC labeler code 72205. The labeler is the company responsible for the label; it may be the manufacturer, a repackager or a distributor.

What other NDCs exist for olmesartan medoxomil-hydrochlorothiazide?

8 other product NDCs are listed under this name.

Is there a related HCPCS / J-code?

Not in Med-Code's curated HCPCS directory.

olmesartan medoxomil-hydrochlorothiazide NDC 72205-147

NDC codes

FDA NDC Directory

Product NDC (as listed)72205-147Labeler and product segments. Claims need a package NDC.

Product NDC at billing width72205-0147Add the package segment from the table below.

Package NDCs as listed with the FDA, and the 11-digit 5-4-2 form used on claims. The highlighted digit is the added leading zero.
Package NDC	11-digit (billing)	Package
72205-147-30	7220501473072205014730	30 TABLET, FILM COATED in 1 BOTTLE (72205-147-30)Marketed from Sep 30, 2025
72205-147-90	7220501479072205014790	90 TABLET, FILM COATED in 1 BOTTLE (72205-147-90)Marketed from Sep 30, 2025
72205-147-99	7220501479972205014799	1000 TABLET, FILM COATED in 1 BOTTLE (72205-147-99)Marketed from Sep 30, 2025

How the 11-digit form is made: The product segment has 3 digits, so one leading zero is added to it (5-3-2 → 5-4-2). Formatting the NDC does not by itself make it billable — the product, package and quantity must match what was dispensed or administered, and payer rules apply. Conversion rules

Product information

Brand name (proprietary): olmesartan medoxomil-hydrochlorothiazide
Generic name (nonproprietary): olmesartan medoxomil-hydrochlorothiazide
Active ingredients: Olmesartan medoxomil — 20 mg/1Hydrochlorothiazide — 12.5 mg/1
Dosage form: Tablet, Film coated
Route: Oral
Labeler: Novadoz Pharmaceuticals LLCNDC labeler code 72205
Product type: Prescription drug
Marketing category: ANDA — Abbreviated New Drug Application (generic)Application ANDA 217398
Marketing start: Sep 26, 2025
Listing expires: Dec 31, 2027
Other FDA classes: Angiotensin 2 Receptor Antagonists (Mechanism)Increased Diuresis (Physiologic effect)Thiazides (Chemical structure)
Identifiers: Product ID 72205-147_c8197eea-e990-4c0e-bc2d-f080bac8de17SPL ID c8197eea-e990-4c0e-bc2d-f080bac8de17SPL set ID c8197eea-e990-4c0e-bc2d-f080bac8de17RxCUI 403853, 403854, 403855UNII 0J48LPH2TH, 6M97XTV3HDUPC 0372205148307, 0372205147300, 0372205147904, 0372205148994, 0372205149304, 0372205148901, 0372205147997, 0372205149991, 0372205149908
Pharmacologic class: Angiotensin 2 Receptor Blocker; Thiazide Diuretic

Billing references

What Med-Code can say about coding this product, and where each statement comes from. Nothing here is inferred from the name alone.

HCPCS codeNo match

No HCPCS code in Med-Code's directory. Oral products like this are usually dispensed by a pharmacy and billed by NDC.

NDC on a medical claim

N472205014730 followed by a unit qualifier and the quantity

Package 72205-0147-30. Unit qualifiers: F2 (international unit), GR (gram), ME (milligram), ML (milliliter), UN (unit (each)). The qualifier and quantity depend on what was given. About the N4 qualifier

Product label

Current FDA label (SPL), effective Sep 26, 2025. This label includes a boxed warning.

Indications (excerpt from the label)

Olmesartan medoxomil and hydrochlorothiazide tablets are indicated for the treatment of hypertension, to lower blood pressure [see Dosage and Administration (2)]. Lowering blood pressure reduces the risk of fatal and nonfatal cardiovascular (CV) events, primarily strokes and myocardial infarctions. These benefits have been seen in controlled trials of antihypertensive drugs from a wide variety of pharmacologic classes including the class to which this drug principally belongs. There are no controlled trials demonstrating risk reduction with olmesartan medoxomil and hydrochlorothiazide tablets. Control of high blood pressure should be part of comprehensive cardiovascular risk management, incl…

Excerpt only. Read the full label for complete information.

Full label on DailyMed (opens in a new tab)

About NDC 72205-147

What is NDC 72205-147?: 72205-147 is the product NDC for olmesartan medoxomil-hydrochlorothiazide, Olmesartan medoxomil 20 mg/1; Hydrochlorothiazide 12.5 mg/1 tablet, film coated, listed with the FDA by Novadoz Pharmaceuticals LLC. It has 3 package NDCs, shown above in 10- and 11-digit form.
What drug is associated with this NDC?: olmesartan medoxomil-hydrochlorothiazide.
What is the active ingredient?: Olmesartan medoxomil, Hydrochlorothiazide.
Who is the labeler?: Novadoz Pharmaceuticals LLC, NDC labeler code 72205. The labeler is the company responsible for the label; it may be the manufacturer, a repackager or a distributor.
What other NDCs exist for olmesartan medoxomil-hydrochlorothiazide?: 8 other product NDCs are listed under this name. See all olmesartan medoxomil-hydrochlorothiazide NDCs.
Is there a related HCPCS / J-code?: Not in Med-Code's curated HCPCS directory. See Billing references above.

Other finished products listed under the same name: strengths, forms and labelers.

Other olmesartan medoxomil-hydrochlorothiazide NDCs
Product	Strength	Form · route	Labeler	Product NDC	Package NDCs (11-digit)
olmesartan medoxomil-hydrochlorothiazide	Olmesartan medoxomil 20 mg/1; Hydrochlorothiazide 12.5 mg/1	Tablet, Film coatedOral	AvKARE	73190-078	73190-0078-90
olmesartan medoxomil-hydrochlorothiazide	Olmesartan medoxomil 40 mg/1; Hydrochlorothiazide 12.5 mg/1	Tablet, Film coatedOral	AvKARE	73190-079	73190-0079-90
olmesartan medoxomil-hydrochlorothiazide	Olmesartan medoxomil 40 mg/1; Hydrochlorothiazide 25 mg/1	Tablet, Film coatedOral	AvKARE	73190-080	73190-0080-90
olmesartan medoxomil-hydrochlorothiazide	Olmesartan medoxomil 40 mg/1; Hydrochlorothiazide 12.5 mg/1	Tablet, Film coatedOral	Novadoz Pharmaceuticals LLC	72205-148	72205-0148-3072205-0148-9072205-0148-99
olmesartan medoxomil-hydrochlorothiazide	Olmesartan medoxomil 40 mg/1; Hydrochlorothiazide 25 mg/1	Tablet, Film coatedOral	Novadoz Pharmaceuticals LLC	72205-149	72205-0149-3072205-0149-9072205-0149-99
olmesartan medoxomil-hydrochlorothiazide	Olmesartan medoxomil 20 mg/1; Hydrochlorothiazide 12.5 mg/1	Tablet, Film coatedOral	AvKARE	42291-924	42291-0924-90
olmesartan medoxomil-hydrochlorothiazide	Olmesartan medoxomil 40 mg/1; Hydrochlorothiazide 12.5 mg/1	Tablet, Film coatedOral	AvKARE	42291-925	42291-0925-90
olmesartan medoxomil-hydrochlorothiazide	Olmesartan medoxomil 40 mg/1; Hydrochlorothiazide 25 mg/1	Tablet, Film coatedOral	AvKARE	42291-926	42291-0926-90

Other NDCs under ANDA 217398

Products listed under the same FDA application: other strengths and forms, and repackagers who relabel the same product.

FDA NDC Directory listings under ANDA 217398
Product	Strength	Form · route	Labeler	Product NDC
olmesartan medoxomil-hydrochlorothiazide	Olmesartan medoxomil 40 mg/1; Hydrochlorothiazide 12.5 mg/1	Tablet, Film coatedOral	Novadoz Pharmaceuticals LLC	72205-148
olmesartan medoxomil-hydrochlorothiazide	Olmesartan medoxomil 40 mg/1; Hydrochlorothiazide 25 mg/1	Tablet, Film coatedOral	Novadoz Pharmaceuticals LLC	72205-149